telehealth glp-1 crackdown news FDA takes aim at companies for promoting unofficial weight loss drug dupes Beth Siemer and Brian Malkin

Notably, cotadutide also alleviated fibrosis to a greater extent than liraglutide or obeticholic acid, despite dose adjustment to achieve similar weight loss in two preclinical mouse models of NASH

Steyn, F

The Post-GLP-1 Cliff That Most People Hit Theres a problem with every GLP-1 medication that the marketing wont mention

For many people, those early symptoms are part of a bigger adjustment period described in our weight loss biology article

Clinical Medicine Insights: Cardiology

The authors speculate that this could be due to off-label prescribing or individuals acquiring medications through non-medical routes such as online purchases